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Identity 
Phylum: Soft Tissue Tumors: Uncertain differentiation: Synovial sarcoma. 
Alias : t(X;18)(p11.2;q11.2) in synovial sarcoma 
 
t(X;18)(p11.2;q11.2) in synovial sarcoma G-banding - Courtesy Charles Bangs. 
 
Clinics and pathology 
Epidemiology 
Rare soft tissue tumor, it accounts for up to 5 to 8% of 
soft tissue sarcomas, the fourth most common type of 
sarcoma after malignant fibrous histyocytoma, 
liposarcoma and rhabdomyosarcoma; the most 
common pediatric non rhabdomyosarcomatous soft 
tissue cancer; average incidence: 2,75 per 100000 
population based on a canandian study. 
Clinics 
Most prevalent in adolescents and young adults, it 
occurs primarily in the para-articular regions of the 
extremities, especially the lower ones; rarely, it is 
encountered in various areas such as parapharyngeal 
region, abdominal wall, lung or cardiac tissue, …. 
Pathology 
Well-defined, apparently unrelated to synovium (cf 
various rare localisations), it displays characteris ics of 
concurrent epithelial and spindle cell proliferation; 
several types are recognized: two major ones: 
Biphasic, with epithelial and spindle cell components i  
various proportions and 
Monophasic fibrous type; 
Monophasic epithelial type is much less common; 
May also present as a poorly differentiated small cell
neoplasm; diagnosis may be difficult especially for the 
two later. 
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In general, very few problems in diagnosis in the 
biphasic type, may be not ascertained in some instances 
even after immunohistochemical examination. 
Treatment 
Complete surgical excision of the primary tumor is 
actually the basis of the treatment; the optimal 
treatment approach is to be determined as post 
operative radiotherapy and adjuvant chemotherapy may 
permit limb preserving surgery and limit local 
recurrence and (micro) metastasis disease (lung+++). 
Prognosis 
Traditionnally has had a bad prognosis what either  
biphasic or monophasic type, poorer in the poorly 
differentiated small cell neoplasm. 
EFS at 5 years: 45-60%; improved in a recent german 
study to 74% for children and adolescents; 
improvements in adults too. 
Recents prognostic studies to identify risk groups and 
adequate treatment strategies indicate that 




A t(X;18)(p11.2;q11.2) is found in almost all synovial 
sarcomas (80%) whatsoever the histologic type may be; 
t(X;18)(p11.2;q11.2) seems to be specific: it is not 
found in other spindle cell sarcomas, and very rarely 
detected in other tumors as malignant fibrous 
histyocytoma or fibrosarcomas. 
Cytogenetics Molecular 
Detectable by metaphasic and/or interphasic dual 
colour fluorescent in situ cytogenetics; hybridization 
combining centomere X or 18 probes with respectively 
18 or X whole chromosome painting or YAC probes. 
Additional anomalies 
Both numerical and structural anomalies are found in 
50% of cases, numerical anomalies only in 20% 
(+7,+8,+12,+21,-3, -11, -14, -22) and 
structural.anomalies only in 20% (involving 
chromosomes 1, 3, 11, 12, 15, 17 and 21: tumors may 
be hypodiploid, pseudodiploid, hyperdiploid or near 
tetraploid without a common pattern; DNA flow 
cytometry study revealed poorer prognosis for 
aneuploid tumors. 
Variants 
A few variants have been described, involving 
chromosomes 1, 3, 15 or 21,...; masked translocations 
were identified as t(5 ;18), t(X ;7) without chromosome 




Genes involved and proteins 
SYT (Synovial tumor) 
Location 
18q11.2 
DNA / RNA 
3,7 kb mRNA. 
Protein 
387 amino acids; glutamin, prolin and glycin rich; t ree 
potential SH2 binding domains and one SH3; widely 
expressed, limited to cartlagenous and nervous tissues 
in early embryonal development; biological properties 
still unknown. 




DNA / RNA 
1,6 kb mRNA. 
Protein 
188 amino acids; 81% homologie for SSX1 and SSX2; 
Kruppel associated box (KRAB) homology; restricted 
expression to testis and thyroid; biological properties 
still unknown. 




5 prime SYT- 3 prime SSX1/2. 
Fusion Protein 
Description 
Substitution of the 8 last amino acids of SYT by 78 
amino acids of SSX, with exclusion of KRAB and one 
SH2 domain. 
Oncogenesis 
The important role is that of the transcript situated on 
the der(X). 
RT-PCR diagnosis: there is a correlation between 
biphasic type and SYT/SSX1 variant (where SSX2 
involvement is never detected), SYT/SSX2 is more 
common than SYT/SSX1 in monophasic one. 
SYT/SSX1 variant might be less favorable, associated 
with higher tumor proliferating rate and reduced overall 
survival (metastasis free survival 42% vs 80%). 
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